We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

MRI-Directed Contrast-Enhanced Mammography Improves Detection of Breast Lesions

By MedImaging International staff writers
Posted on 31 Aug 2022
Print article
Image: MRI-directed CEM detects a higher fraction of suspicious MRI lesions (Photo courtesy of Unsplash)
Image: MRI-directed CEM detects a higher fraction of suspicious MRI lesions (Photo courtesy of Unsplash)

Suspicious lesions detected on contrast-enhanced breast MRI often undergo targeted ultrasound evaluation to determine if they are amenable to ultrasound-guided biopsy. A new study aimed to assess the utility of MRI-directed contrast-enhanced mammography (CEM) performed for biopsy planning of suspicious MRI-detected breast lesions, with comparison to MRI-directed ultrasound. The study found that MRI-directed CEM detects a higher fraction of suspicious MRI lesions than MRI-directed ultrasound and also detects a higher fraction than either method individually.

The retrospective study by researchers at the University of Virginia Health System (Charlottesville, VA, USA) included 120 patients (median age, 50.3 years) who underwent MRI-directed CEM from September 2014 to July 2020 for biopsy planning of a total of 140 suspicious breast MRI lesions; 109 lesions were also evaluated by MRI-directed ultrasound at the same visit. Reference standard was histopathology or at least two years of imaging follow-up for benign lesions. Rates of detecting a correlate for the MRI lesion, among all lesions and among malignant lesions, were compared between MRI-directed CEM, MRI-directed ultrasound, and combined MRI-directed CEM and ultrasound (i.e., correlate detected on either modality) using McNemar's test. Frequencies of imaging modalities used for biopsy guidance after MRI-directed imaging were determined.

The study revealed that 21 of 109 lesions were malignant. The lesion detection rate was higher for MRI-directed CEM than for MRI-directed ultrasound [69.7% (76/109) vs 45.9% (50/109); p<.001], and higher for combined MRI-directed CEM and ultrasound [77.1% (84/109)] than for either MRI-directed CEM (p=.008) or MRI-directed ultrasound (p<.001). The malignant lesion detection rate was not significantly different between MRI-directed CEM and MRI-directed ultrasound [95.7% (22/23) vs. 78.3% (18/23); p=.13]. A total of 31.2% (34/109) of lesions were seen only on MRI-directed CEM, and 7.3% (8/109) were seen only on MRI-directed ultrasound. A total of 17.4% (4/23) of malignant lesions were seen only on MRI-directed CEM, and none were seen only on MRI-directed ultrasound. Among lesions recommended for biopsy, stereotactic- or tomosynthesis-guided biopsy was recommended for 25.2% (26/103), ultrasound-guided biopsy for 35.9% (37/103), and MRI-guided biopsy for 38.8% (40/103).

Based on these findings, the researchers concluded that MRI-directed CEM detects a higher fraction of suspicious MRI lesions than does MRI-directed ultrasound. MRI-directed CEM/ultrasound detects a higher fraction than either method individually. The researchers have suggested that MRI-directed CEM can be a useful alternate or complementary tool to MRI-directed ultrasound in biopsy planning for suspicious MRI lesions, facilitating use of biopsy guidance methods other than MRI guidance.

 

 

Gold Supplier
Premium Ultrasound Scanner
ARIETTA 850
Digital Imaging System
ACQUIDR
Fixed Height Radiographic Table
Stylix
New
Ultrasound Probe Covers
Intuit

Print article
Radcal

Channels

Ultrasound

view channel
Image: The new Clarius MSK AI model speeds up diagnosis and treatment of musculoskeletal injuries (Photo courtesy of Clarius)

Handheld MSK Ultrasound Scanner Uses AI to Automatically Identify and Measure Tendons in Foot, Ankle and Knee

An artificial intelligence (AI) application for musculoskeletal (MSK) imaging that works with handheld point-of-care ultrasound devices automatically identifies, highlights, and measures tendon structures... Read more

Nuclear Medicine

view channel
Image: Tracking radiation treatment in real time promises safer, more effective cancer therapy (Photo courtesy of Pexels)

Real-Time 3D Imaging Provides First-of-Its-Kind View of X-Rays Hitting Inside Body During Radiation Therapy

Radiation is used in treatment for hundreds of thousands of cancer patients each year, bombarding an area of the body with high energy waves and particles, usually X-rays. The radiation can kill cancer... Read more

General/Advanced Imaging

view channel
Image: CZT gamma detector for SPECT imaging (Photo courtesy of Kromek)

Low-Dose Molecular Breast Imaging (MBI) Could Improve Cancer Detection in Dense Breast Tissue

Traditional mammography is often less able to clearly image tumors due to the density of the breast tissue. Molecular breast imaging (MBI) technology uses a radioactive tracer that ‘lights up’ areas of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.